XtalPi
Jing Zhou is a highly experienced research scientist currently employed at XtalPi Inc. since February 2022, with prior roles including Business Development Manager at Elpiscience Biopharmaceuticals, Project Director at NeoX Biotech, and Postdoctoral Fellow positions at The Johns Hopkins University and the National Institutes of Health. Jing Zhou has extensive expertise in antibody structure modeling and development, structural analysis of HIV-1 antibody-antigen complexes, and vaccine design, with a notable publication record. Educational qualifications include a PhD in Computational Biophysics from the University of Tennessee, Knoxville, a Master's degree, and a Bachelor's degree in Environmental Science from Dalian University of Technology.
This person is not in any offices
XtalPi
XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enables pharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.